Dextromethorphan Market

COVID-19 Impact on Global Dextromethorphan Market

• On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the Coronavirus disease (COVID-19) outbreak a public health emergency of international concern. Originating in China, the virus has spread to at least 214 countries and territories around the world.
• Several governments and private sector businesses are operating at a limited capacity or have ceased operations completely due to recent events surrounding the COVID-19 pandemic
• The outbreak of the COVID-19 pandemic has led to disturbance in the supply chain due to the global lockdown in several countries. The dextromethorphan market has been hampered due to the COVID-19 pandemic and nationwide lockdown of several non-essential activities and manufacturing facilities in several countries.
• The market is anticipated to expand at a healthy pace during the forecast period due to the acceptance of new normal conditions and restart of end-use industries in various countries

Key Drivers and Restraints of Dextromethorphan Market

• Demand for dextromethorphan is expected to increase at a significant rate during the forecast period due to high prevalence of cough in population across the globe. Increase in geriatric population, spread of coronavirus, and rise in air pollution are driving the dextromethorphan market.
• Enactment of stringent regulations against the use of dextromethorphan is negatively affecting the dextromethorphan market

Dextromethorphan Market: Product Type Segment

• Based on product type, the dextromethorphan market can be divided into tablets and syrups
• The syrups segment dominates the dextromethorphan market
• Cough syrups are used to treat coughs that occur when one has an upper respiratory tract infection (URTI). Cough can also be a symptom of other conditions such as asthma or lung diseases. Cough syrups are often divided into those for a dry cough and those for a chesty cough.
• Strong demand for cough syrups in the global market is expected to drive the dextromethorphan market during the forecast period

Dextromethorphan Market: Distribution Channel Segment

• Based on distribution channel, the dextromethorphan market can be divided into retail pharmacy, hospital pharmacy, and e-commerce
• Among them, the hospital pharmacy segment dominates the dextromethorphan market. This can be ascribed to the rise in number of hospitals worldwide. Furthermore, cough syrups are prescription-based medications, which are mostly prescribed by specialized health care professionals in hospitals. This is augmenting the segment.
• The e-commerce segment is expected to expand at a rapid pace during the forecast period, owing to the rise in usage of Internet across the globe

Asia-Pacific to Hold Leading Share of Global Dextromethorphan Market

• In terms of region, the dextromethorphan market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
• Asia Pacific is expected to hold major share of the global dextromethorphan market, followed by North America and Europe, during the forecast period
• The market in Asia Pacific is projected to expand at a rapid pace during the forecast period, owing to the rise in usage of cough syrups in the region. Furthermore, the constantly evolving life science industry is driving the market in developing economies such as India, China, and Malaysia.

Key Manufacturers Operating in Global Dextromethorphan Market

The dextromethorphan market was consolidated in 2020. Major players have prominent presence in developed and developing countries. Key manufacturers operating in the dextromethorphan market include:

• AstraZeneca
• ACETO
• Aurobindo Pharma
• Sandoz
• Mylan
• Sun Pharmaceutical
• Teva
• Zydus Pharmaceuticals
• Unique Pharmaceuticals
• Ipca Laboratories
• Intas Pharmaceuticals

Dextromethorphan Market: Research Scope

Dextromethorphan Market, by Product Type

• Tablets
• Syrups

Dextromethorphan Market, by Application

• Cold
• Acute or Chronic Bronchitis
• Bronchial Asthma
• Sore Throat
• Tuberculosis (TB)

Dextromethorphan Market, by Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• E-commerce

Global Dextromethorphan Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia & CIS
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Dextromethorphan Market: Introduction

• Dextromethorphan belongs to a class of drugs known as cough suppressants drugs
• It shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. Dextromethorphan acts on a part of the brain (cough center) to reduce the urge to cough.
• It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity
• Dextromethorphan can affect drugs that treat depression. Some combination of cold and cough medicines contain decongestants, which can raise blood pressure.